180 related articles for article (PubMed ID: 17608855)
1. Effects of nonalcoholic fatty liver disease on the development of metabolic disorders.
Fan JG; Li F; Cai XB; Peng YD; Ao QH; Gao Y
J Gastroenterol Hepatol; 2007 Jul; 22(7):1086-91. PubMed ID: 17608855
[TBL] [Abstract][Full Text] [Related]
2. NAFLD as a risk factor for the development of diabetes and the metabolic syndrome: an eleven-year follow-up study.
Adams LA; Waters OR; Knuiman MW; Elliott RR; Olynyk JK
Am J Gastroenterol; 2009 Apr; 104(4):861-7. PubMed ID: 19293782
[TBL] [Abstract][Full Text] [Related]
3. Metabolic significance of nonalcoholic fatty liver disease in nonobese, nondiabetic adults.
Kim HJ; Kim HJ; Lee KE; Kim DJ; Kim SK; Ahn CW; Lim SK; Kim KR; Lee HC; Huh KB; Cha BS
Arch Intern Med; 2004 Oct; 164(19):2169-75. PubMed ID: 15505132
[TBL] [Abstract][Full Text] [Related]
4. Significant correlations between severe fatty liver and risk factors for metabolic syndrome.
Hsiao PJ; Kuo KK; Shin SJ; Yang YH; Lin WY; Yang JF; Chiu CC; Chuang WL; Tsai TR; Yu ML
J Gastroenterol Hepatol; 2007 Dec; 22(12):2118-23. PubMed ID: 18031368
[TBL] [Abstract][Full Text] [Related]
5. Risk factors associated with nonalcoholic fatty liver disease and its relationship with the hepatic histological changes.
Rodríguez-Hernández H; Gonzalez JL; Márquez-Ramirez MD; Flores-Hernandez M; Rodríguez-Morán M; Guerrero-Romero F
Eur J Gastroenterol Hepatol; 2008 May; 20(5):399-403. PubMed ID: 18403941
[TBL] [Abstract][Full Text] [Related]
6. Frequency and predictors of nonalcoholic fatty liver disease in myotonic dystrophy.
Shieh K; Gilchrist JM; Promrat K
Muscle Nerve; 2010 Feb; 41(2):197-201. PubMed ID: 19813185
[TBL] [Abstract][Full Text] [Related]
7. Persistent elevation of liver function enzymes within the reference range is associated with increased cardiovascular risk in young adults: the Bogalusa Heart Study.
Patel DA; Srinivasan SR; Xu JH; Chen W; Berenson GS
Metabolism; 2007 Jun; 56(6):792-8. PubMed ID: 17512312
[TBL] [Abstract][Full Text] [Related]
8. [Effect of body weight mass and its change on the incidence of nonalcoholic fatty liver disease].
Fan JG; Zhou Q; Wo QH
Zhonghua Gan Zang Bing Za Zhi; 2010 Sep; 18(9):676-9. PubMed ID: 20943079
[TBL] [Abstract][Full Text] [Related]
9. [The relationship between serum adiponectin level and serum alanine aminotransferase elevation in Korean male with nonalcoholic fatty liver disease].
Lee YS; Cho YK; Pae JC; Oh SY; Kang MS; Park JH; Kim HJ; Park DI; Sohn CI; Jeon WK; Kim BI; Lee WY; Oh KW; Yun EJ; Oh ES
Korean J Hepatol; 2006 Jun; 12(2):221-9. PubMed ID: 16804347
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study.
Bedogni G; Miglioli L; Masutti F; Tiribelli C; Marchesini G; Bellentani S
Hepatology; 2005 Jul; 42(1):44-52. PubMed ID: 15895401
[TBL] [Abstract][Full Text] [Related]
11. Apnoeic-hypopnoeic episodes during obstructive sleep apnoea are associated with histological nonalcoholic steatohepatitis.
Mishra P; Nugent C; Afendy A; Bai C; Bhatia P; Afendy M; Fang Y; Elariny H; Goodman Z; Younossi ZM
Liver Int; 2008 Sep; 28(8):1080-6. PubMed ID: 18647236
[TBL] [Abstract][Full Text] [Related]
12. Effect of a hypocaloric diet in transaminases in nonalcoholic fatty liver disease and obese patients, relation with insulin resistance.
de Luis DA; Aller R; Izaola O; Sagrado MG; Conde R; Gonzalez JM
Diabetes Res Clin Pract; 2008 Jan; 79(1):74-8. PubMed ID: 17766001
[TBL] [Abstract][Full Text] [Related]
13. Cholelithiasis and markers of nonalcoholic fatty liver disease in patients with metabolic risk factors.
Koller T; Kollerova J; Hlavaty T; Huorka M; Payer J
Scand J Gastroenterol; 2012 Feb; 47(2):197-203. PubMed ID: 22182015
[TBL] [Abstract][Full Text] [Related]
14. Metformin use in children with nonalcoholic fatty liver disease: an open-label, 24-month, observational pilot study.
Nobili V; Manco M; Ciampalini P; Alisi A; Devito R; Bugianesi E; Marcellini M; Marchesini G
Clin Ther; 2008 Jun; 30(6):1168-76. PubMed ID: 18640473
[TBL] [Abstract][Full Text] [Related]
15. Iron depletion by phlebotomy improves insulin resistance in patients with nonalcoholic fatty liver disease and hyperferritinemia: evidence from a case-control study.
Valenti L; Fracanzani AL; Dongiovanni P; Bugianesi E; Marchesini G; Manzini P; Vanni E; Fargion S
Am J Gastroenterol; 2007 Jun; 102(6):1251-8. PubMed ID: 17391316
[TBL] [Abstract][Full Text] [Related]
16. Nonalcoholic fatty liver disease among patients with hypothalamic and pituitary dysfunction.
Adams LA; Feldstein A; Lindor KD; Angulo P
Hepatology; 2004 Apr; 39(4):909-14. PubMed ID: 15057893
[TBL] [Abstract][Full Text] [Related]
17. Serum retinol binding protein 4 and nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus.
Wu H; Jia W; Bao Y; Lu J; Zhu J; Wang R; Chen Y; Xiang K
Diabetes Res Clin Pract; 2008 Feb; 79(2):185-90. PubMed ID: 17904683
[TBL] [Abstract][Full Text] [Related]
18. A double-blind randomized placebo-controlled trial of orlistat for the treatment of nonalcoholic fatty liver disease.
Zelber-Sagi S; Kessler A; Brazowsky E; Webb M; Lurie Y; Santo M; Leshno M; Blendis L; Halpern Z; Oren R
Clin Gastroenterol Hepatol; 2006 May; 4(5):639-44. PubMed ID: 16630771
[TBL] [Abstract][Full Text] [Related]
19. Long-term prognosis of nonalcoholic fatty liver disease: is pharmacological therapy actually necessary?
Cinar K; Coban S; Idilman R; Tuzun A; Sarioglu M; Bektas M; Erden E; Bozkaya H; Ozden A
J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 1):169-73. PubMed ID: 16706829
[TBL] [Abstract][Full Text] [Related]
20. Prevalence and associated risk factors of non-alcoholic fatty liver disease in hospitalized patients.
Radu C; Grigorescu M; Crisan D; Lupsor M; Constantin D; Dina L
J Gastrointestin Liver Dis; 2008 Sep; 17(3):255-60. PubMed ID: 18836616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
